Steve Young
Chief Tech/Sci/R&D Officer bei ARCUS BIOSCIENCES, INC.
Profil
Steve Young is currently working as the Senior VP-Technology & Quantitative Biology at Arcus Biosciences, Inc. He previously worked as the Executive Director-Lead Discovery at Amgen, Inc. from 2004 to 2013, and as the Director-Lead Discovery at Tularik, Inc. from 2001 to 2004.
He also held positions as the Director at the Society for Laboratory Automation & Screening from 2017 to 2019, the Vice President-Technology at Flexus Biosciences, Inc. from 2013 to 2015, and the Head-High Throughput Screening at Roche Healthcare Ltd.
from 1999 to 2001.
Additionally, he worked as the Vice President-Technology at Rapt Therapeutics, Inc. in 2015.
Dr. Young obtained his undergraduate and doctorate degrees from the University of Bristol in 1991 and 1994, respectively.
Aktive Positionen von Steve Young
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01.03.2016 |
Ehemalige bekannte Positionen von Steve Young
| Unternehmen | Position | Ende |
|---|---|---|
Society for Laboratory Automation & Screening
 Society for Laboratory Automation & Screening Miscellaneous Commercial ServicesCommercial Services The Society for Laboratory Automation & Screening (SLAS) sets standards for microplate development through its Microplate Standards Advisory Committee. The non-profit company is based in St. Charles, IL. SLAS offers various platforms for education, scientific publishing, collaboration, networking, and career advancement for its international community. The company has developed a new micro-credentials program exclusively for the life sciences industry. SLAS's mission is to connect laboratory technology providers with laboratory technology users. | Director/Board Member | 01.01.2019 |
| RAPT THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.11.2015 |
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Chief Tech/Sci/R&D Officer | 01.04.2015 |
| AMGEN INC. | Corporate Officer/Principal | 01.07.2013 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Steve Young
| University of Bristol | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Society for Laboratory Automation & Screening
Society for Laboratory Automation & Screening Miscellaneous Commercial ServicesCommercial Services The Society for Laboratory Automation & Screening (SLAS) sets standards for microplate development through its Microplate Standards Advisory Committee. The non-profit company is based in St. Charles, IL. SLAS offers various platforms for education, scientific publishing, collaboration, networking, and career advancement for its international community. The company has developed a new micro-credentials program exclusively for the life sciences industry. SLAS's mission is to connect laboratory technology providers with laboratory technology users. | Commercial Services |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Health Technology |
Roche Healthcare Ltd.
 Roche Healthcare Ltd. Medical/Nursing ServicesHealth Services Roche Healthcare Ltd. provides residential and nursing services. It offers care homes, home care support, and Roche training solutions. The company was founded by Patrick Roche in 1995 and is headquartered in Leeds, the United Kingdom. | Health Services |
